Patent Ductus Arteriosus: Perinatal Risk Factors

Detalhes bibliográficos
Autor(a) principal: Nizarali, Z
Data de Publicação: 2012
Outros Autores: Marques, T, Costa, C, Barroso, R, Cunha, M
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Texto Completo: http://hdl.handle.net/10400.10/1486
Resumo: Background: Patent Ductus Arteriosus (PDA) is the most common heart disease among the newborn population. Besides prematurity, other factors are believed to play a significant role in this condition. Aims: Identification of perinatal risk factors associated with PDA in premature or Very Low Birth Weight Infants (VLBW). Material and methods: Transversal study including all infants admitted to a Level III Neonatal Intensive Care Unit, from January 2005 to December 2009 and included in the Very Low Birth Weight Portuguese National Database . Clinical and demographic data were analysed using a logistic regression analysis to identify risk factors for PDA. Results: A total of 318 VLBW or less than 32 weeks Gestational Age (GA) infants were enrolled, 53.6% males. Infants presenting PDA (100; 31.4%) had a lower mean BW ( 914,19 versus 1257,44 grams; p<0.001) and a lower mean GA (27.06 versus 29.77 weeks; p<0.0001). Using univariate logistic regression, both lower BW [OR: 0.99; CI (95%): 0.995-0.997] and lower GA [OR: 0.68; CI (95%): 0.61-0.75] were important risk factors for PDA. Other factors increasing the risk of PDA were: lower Apgar scores at one [OR: 0.77; CI (95%): 0.68-0.86] and five minutes [OR:0.73;CI (95%): 0.62-0.86]; need for resuscitation in the delivery room [OR: 13.1;CI(95%):3.11-55.1]; surfactant administration [OR:8.12;CI(95%):4.13-15.95]; higher CRIB score [OR:1.17;CI(95%): 1.11-1.24], and higher SNAPPEII score [OR: 1.03; CI (95%): 1.02-1.04]. The logistic multivariate regression model using all these variables identified BW [OR: 0.997; CI (95%): 0.996- 0.998] and surfactant treatment [OR: 3.99; CI (95%): 1.903-8.386] as the only risk factors contributing with statistical significance. The analysis of the ROC curve showed a predictive positive value of 82%. Discussion: The most important risk factors were the use of surfactant and BW, the latter increasing by 23%, the risk of PDA for fewer 100 grams. Although surfactant treatment leads to improved respiratory outcomes and survival in VLBW infants, it increased the risk of PDA by an almost fourfold.
id RCAP_6778b3a711c8481d3b7007c09e303fcd
oai_identifier_str oai:repositorio.hff.min-saude.pt:10400.10/1486
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Patent Ductus Arteriosus: Perinatal Risk FactorsPatent ductus arteriosusPerinatal riskVery low birth weightBackground: Patent Ductus Arteriosus (PDA) is the most common heart disease among the newborn population. Besides prematurity, other factors are believed to play a significant role in this condition. Aims: Identification of perinatal risk factors associated with PDA in premature or Very Low Birth Weight Infants (VLBW). Material and methods: Transversal study including all infants admitted to a Level III Neonatal Intensive Care Unit, from January 2005 to December 2009 and included in the Very Low Birth Weight Portuguese National Database . Clinical and demographic data were analysed using a logistic regression analysis to identify risk factors for PDA. Results: A total of 318 VLBW or less than 32 weeks Gestational Age (GA) infants were enrolled, 53.6% males. Infants presenting PDA (100; 31.4%) had a lower mean BW ( 914,19 versus 1257,44 grams; p<0.001) and a lower mean GA (27.06 versus 29.77 weeks; p<0.0001). Using univariate logistic regression, both lower BW [OR: 0.99; CI (95%): 0.995-0.997] and lower GA [OR: 0.68; CI (95%): 0.61-0.75] were important risk factors for PDA. Other factors increasing the risk of PDA were: lower Apgar scores at one [OR: 0.77; CI (95%): 0.68-0.86] and five minutes [OR:0.73;CI (95%): 0.62-0.86]; need for resuscitation in the delivery room [OR: 13.1;CI(95%):3.11-55.1]; surfactant administration [OR:8.12;CI(95%):4.13-15.95]; higher CRIB score [OR:1.17;CI(95%): 1.11-1.24], and higher SNAPPEII score [OR: 1.03; CI (95%): 1.02-1.04]. The logistic multivariate regression model using all these variables identified BW [OR: 0.997; CI (95%): 0.996- 0.998] and surfactant treatment [OR: 3.99; CI (95%): 1.903-8.386] as the only risk factors contributing with statistical significance. The analysis of the ROC curve showed a predictive positive value of 82%. Discussion: The most important risk factors were the use of surfactant and BW, the latter increasing by 23%, the risk of PDA for fewer 100 grams. Although surfactant treatment leads to improved respiratory outcomes and survival in VLBW infants, it increased the risk of PDA by an almost fourfold.OMICS GroupUnidade Local de Saúde Amadora / SintraNizarali, ZMarques, TCosta, CBarroso, RCunha, M2015-08-14T13:58:56Z20122012-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.10/1486eng2167-0897info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-03-10T15:03:36Zoai:repositorio.hff.min-saude.pt:10400.10/1486Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T01:16:41.848070Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Patent Ductus Arteriosus: Perinatal Risk Factors
title Patent Ductus Arteriosus: Perinatal Risk Factors
spellingShingle Patent Ductus Arteriosus: Perinatal Risk Factors
Nizarali, Z
Patent ductus arteriosus
Perinatal risk
Very low birth weight
title_short Patent Ductus Arteriosus: Perinatal Risk Factors
title_full Patent Ductus Arteriosus: Perinatal Risk Factors
title_fullStr Patent Ductus Arteriosus: Perinatal Risk Factors
title_full_unstemmed Patent Ductus Arteriosus: Perinatal Risk Factors
title_sort Patent Ductus Arteriosus: Perinatal Risk Factors
author Nizarali, Z
author_facet Nizarali, Z
Marques, T
Costa, C
Barroso, R
Cunha, M
author_role author
author2 Marques, T
Costa, C
Barroso, R
Cunha, M
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Unidade Local de Saúde Amadora / Sintra
dc.contributor.author.fl_str_mv Nizarali, Z
Marques, T
Costa, C
Barroso, R
Cunha, M
dc.subject.por.fl_str_mv Patent ductus arteriosus
Perinatal risk
Very low birth weight
topic Patent ductus arteriosus
Perinatal risk
Very low birth weight
description Background: Patent Ductus Arteriosus (PDA) is the most common heart disease among the newborn population. Besides prematurity, other factors are believed to play a significant role in this condition. Aims: Identification of perinatal risk factors associated with PDA in premature or Very Low Birth Weight Infants (VLBW). Material and methods: Transversal study including all infants admitted to a Level III Neonatal Intensive Care Unit, from January 2005 to December 2009 and included in the Very Low Birth Weight Portuguese National Database . Clinical and demographic data were analysed using a logistic regression analysis to identify risk factors for PDA. Results: A total of 318 VLBW or less than 32 weeks Gestational Age (GA) infants were enrolled, 53.6% males. Infants presenting PDA (100; 31.4%) had a lower mean BW ( 914,19 versus 1257,44 grams; p<0.001) and a lower mean GA (27.06 versus 29.77 weeks; p<0.0001). Using univariate logistic regression, both lower BW [OR: 0.99; CI (95%): 0.995-0.997] and lower GA [OR: 0.68; CI (95%): 0.61-0.75] were important risk factors for PDA. Other factors increasing the risk of PDA were: lower Apgar scores at one [OR: 0.77; CI (95%): 0.68-0.86] and five minutes [OR:0.73;CI (95%): 0.62-0.86]; need for resuscitation in the delivery room [OR: 13.1;CI(95%):3.11-55.1]; surfactant administration [OR:8.12;CI(95%):4.13-15.95]; higher CRIB score [OR:1.17;CI(95%): 1.11-1.24], and higher SNAPPEII score [OR: 1.03; CI (95%): 1.02-1.04]. The logistic multivariate regression model using all these variables identified BW [OR: 0.997; CI (95%): 0.996- 0.998] and surfactant treatment [OR: 3.99; CI (95%): 1.903-8.386] as the only risk factors contributing with statistical significance. The analysis of the ROC curve showed a predictive positive value of 82%. Discussion: The most important risk factors were the use of surfactant and BW, the latter increasing by 23%, the risk of PDA for fewer 100 grams. Although surfactant treatment leads to improved respiratory outcomes and survival in VLBW infants, it increased the risk of PDA by an almost fourfold.
publishDate 2012
dc.date.none.fl_str_mv 2012
2012-01-01T00:00:00Z
2015-08-14T13:58:56Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.10/1486
url http://hdl.handle.net/10400.10/1486
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2167-0897
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv OMICS Group
publisher.none.fl_str_mv OMICS Group
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833600903552172032